Dementia with Lewy bodies (DLB) is a complex condition that shares features with both Alzheimer’s disease and Parkinson’s ...

HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.

ZUNVEYL (benzgalantamine) is a twice-daily treatment designed to address the cognitive symptoms of mild-to-moderate Alzheimer’s disease. By enhancing cholinergic function in the brain, ZUNVEYL ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

A recent trial on gantenerumab showed that the drug could reduce the risk of Alzheimer’s symptoms by 50% in pre-symptomatic ...

In Kenya, the Alzheimer’s and Dementia Organisation Kenya (ADOK) estimates that around 60,000 people are affected, a number ...

Your doctor may prescribe a type of drug called a cholinesterase inhibitor, most commonly donepezil (Aricept), rivastigmine (Exelon), or galantamine (Razadyne). By blocking breakdown of an ...

Research shows how specific natural nootropics can enhance memory, focus, and cognitive processing while potentially offering better safety profiles.

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...